Turn Therapeutics Inc. (TTRX) stock
TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.35−0.79 (-7.75%)
Close on Nov 13, 2026Market cap $278.37MP/E –Yield –
Turn Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Turn Therapeutics's enterprise value was $310.97M on Nov 11, 2026, against $95.53M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $310.97M | +189.8% |
| 2025 | Dec 31, 2025 | $107.30M | – |
See a number that looks wrong?